More focus is needed on subtypes of lung cancer that do not have FDA-approved targeted therapies
How do side effects from immunotherapy differ from side effects from chemotherapy in lung cancer?
The BILCAP study: a better overal survivial of biliary tract cancers with adjuvant capecitabine
Olanzapine for nausea control in chemotherapy-treated patients
ASCEND-1 and ASCEND-2: Ceritinib for ALK-rearranged NSCLC and baseline brain metastases